Mosharraf Hossain

24-Year-Old All RounderAll Rounder
Cumilla Warriors

Bangladesh

Underwent a successful brain surgery
All RounderComilla Victorians
September 29, 2019
Hossain hopes to play again after he went successful brain surgery, Cricbuzz reports.
ANALYSIS
The Bangladesh all-rounder, who has played five ODIs for his country underwent a successful brain surgery moreover, in March this year during a medical check-up, it was revealed that he had a brain tumor (glioma) after check-up he had gone through days of being severely ill and even fainting on a few occasions. The tests revealed he needed medical attention at the earliest. There is still three therapy left after that he hopes to get back to action in the upcoming National Cricket League and base his future decisions on how he shapes up there.
Read More News
By Format
By Competition
Batting Stats - Format
Loading Batting Stats...
Bowling Stats - Format
Loading Bowling Stats...
Batting Stats - Competition
Loading Batting Stats...
Bowling Stats - Competition
Loading Bowling Stats...
Cricket Game Log - Bowling
Calculate Stats Over Time
Just click on any two dates. * - Dream11 points are currently estimated.
Scoring
Dream11
Loading Bowling Game Log...
Cricket Game Log - Batting
Calculate Stats Over Time
Just click on any two dates. * - Dream11 points are currently estimated.
Scoring
Dream11
Loading Batting Game Log...
Cricket Game Log - Fielding
Calculate Stats Over Time
Just click on any two dates. * - Dream11 points are currently estimated.
Scoring
Dream11
Loading Fielding Game Log...
More Fantasy News
Diagnosed with brain tumour
All RounderComilla Victorians
March 11, 2019
Hossain has been diagnosed with brain tumour and is completing his visa formalities for Singapore where further scans will be conducted, reports ESPN Cricinfo
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Called up for ODI in tied series
All RounderBangladesh
September 29, 2016
Hussain will replace Rubel Hossain in the third ODI against Afghanistan on October 1.
ANALYSIS
Subscribe now to instantly reveal our take on this news.